Clinical Trial Update: Idebenone Treatment of Early Parkinson's Diseasesymptoms [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on idebenone for early Parkinson's disease focusing on oxidative stress as a contributing factor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Oxidative Stress is an Important Cause of Parkinson's Disease | Phase 4 | Status: UNKNOWN